Guru Ownership Trend
Guru Analysis for Krystal Biotech, Inc. (KRYS)
Krystal Biotech, Inc. (KRYS), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $56.18 M.
Top institutional holders include Renaissance Technologies (RenTech) and Ray Dalio.
Institutional sentiment is currently Bullish. This is evidenced by a $17.81 M net inflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who increased their stake by 521.7%. Conversely, Cliff Asness reduced exposure by 0.8%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Krystal Biotech, Inc. (KRYS)
Major holders include Renaissance Technologies (RenTech) ($22.18 M), Ray Dalio ($20.25 M), Ken Fisher ($10.29 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 157,177 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $17.81 M, with 3 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 1 fully exited KRYS. The total reported sell value was $3.82 M.
Yes, 0 managers opened new positions in KRYS, and 3 increased their existing holdings. The total reported buy value was $21.63 M.